CWP
PFE icon

Clark Wealth Partners’s Pfizer PFE Stock Holding History

Clark Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.48K Buy
311
+22
+8% +$575 ﹤0.01% 255
2026
Q1 		$8.13K Sell
289
-536
-65% -$14.3K 0.01% 270
2025
Q4 		$20.5K Hold
825
– – 0.01% 174
2025
Q3 		$20.5K Sell
825
-13,232
-94% -$327K 0.01% 174
2025
Q2 		$341K Sell
14,057
-11
-0.1% -$257 0.23% 41
2025
Q1 		$356K Buy
14,068
+240
+2% +$6.28K 0.26% 38
2024
Q4 		$367K Buy
+13,828
New +$375K 0.28% 39

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clark Wealth Partners's PFE Position: Q2 2026 in Review

Clark Wealth Partners increased its Pfizer (PFE) stake by 7.6% in Q2 2026, buying an estimated $575 and bringing the position to 311 shares worth $7.48K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Clark Wealth Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $367K in Q4 2024. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Clark Wealth Partners held 311 shares of Pfizer worth $7.48K as of Q2 2026.
  • Clark Wealth Partners bought 22 Pfizer shares in Q2 2026, an estimated $575.
  • Pfizer made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #255 holding.
  • Clark Wealth Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's Pfizer position peaked at $367K in Q4 2024.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.